← Evidence map

ArticleAdvances in therapy2026

Indirect Treatment Comparisons of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in Third-Line or Later Relapsed or Refractory Follicular Lymphoma.

Alexander P Boardman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 42138782